Sign up here to receive news updates via email.
-
November 19, 2024 |
Media, News and Updates, Press Releases
BPGbio Recognized as 2024 ‘BioTech AI Company of the Year’ by BioTech Breakthrough Awards
read more -
November 12, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present on Chemical Proteomics Technologies to Enable E2-based Targeted Protein Degradation at Hit ID Summit
read more -
November 7, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and BRG399 at SITC 2024
read more -
October 31, 2024 |
Media, News and Updates, Press Releases
BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
read more -
October 29, 2024 |
Media, News and Updates, Press Releases
BPGbio CEO Niven R. Narain to Present at Google’s Inaugural Cancer AI Symposium
read more -
October 24, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at TPD and Induced Proximity Summit
read more
